Il fallimento di un ducato. Ceti dirigenti, società e volontariato militare a Reggio Emilia
2021-01-01 Solieri, Fabrizio
Clinical and Serological Characteristics of Sjogren's Disease-related Lymphocytic Interstitial Pneumonia: A Large Multicenter Study
2024-01-01 La Rocca, G; Ferro, F; Sebastiani, M; Manfredi, A; Vacchi, C; Bocci, Eb; Nicchi, M; Atzeni, F; Crac, F; Guiducci, S; Cometi, L; Quartuccio, L; Treppo, E; Manfr, V; Mosca, M; Baldini, C
Clinical parameters for first-line immuno-combinations choice in metastatic renal cell carcinoma (mRCC) patients (pts): the Meet-URO 33 study
2024-01-01 Cavasin, N.; Bimabatti, D.; Signori, A.; Basso, U.; Fratino, L.; Bronte, E.; De Tursi, M.; Pierantoni, F.; Ortega, C.; Zago, G.; De Vivo, R.; Buffoni, M.; Bracarda, S.; Iacovelli, R.; Silvia, C.; Fantinel, E.; Rescigno, P.; Banna, G. L.; Buti, S.; Rebuzzi, S. E.
Correlation between body composition (BC) and outcomes in mRCC patients (pts) in first line therapy (1L tp)
2024-01-01 Tchawa Tchamake, J. C.; Baldessari, C.; Farioli, F.; Agresti, G.; Maruzzo, M.; Basso, U.; Buti, S.; Favaretto, A.; D’Agostino, E.; Bacchelli, F.; Oltrecolli, M.; Pirola, M.; Roccabruna, S.; Caffari, E.; Pugliese, G.; Pipitone, S.; Vitale, M. G.; Fiocchi, F.; Dominici, M.; Sabbatini, R.
Overall survival (OS) results in phase II Trial of Cabozantinib (CABO) plus durvalumab (DURVA) in patients with urothelial carcinoma (UC) or non- UC variant histologies (VH) after platinum chemotherapy (ARCADIA).
2024-01-01 Stellato, M.; Polymeropoulos, A.; Guadalupi, V.; Ambrosini, P.; Gusmaroli, E.; Cavalli, C.; Claps, M.; Raggi, D.; Rametta, A.; Ortega, C.; Tucci, M.; Buti, S.; Pipitone, S.; Iacovelli, R.; Calareso, G.; Alessi, A.; Procopio, G.; Miceli, R.; Necchi, A.; Giannatempo, P.
P254 REAl-world Data from an Italian Compassionate Use Program (CUP) of avelumab first- Line Maintenance (1LM) for locallY advanced or metastatic Urothelial Carcinoma (la/mUC): Outcomes from the READY study in patients (pts) with low tumor burden
2024-01-01 Antonuzzo, L.; Maruzzo, M.; De Giorgi, U.; Santini, D.; Tambaro, R.; Buti, S.; Carrozza, F.; Calabrò, F.; Di Lorenzo, G.; Fornarini, G.; Iacovelli, R.; Cullurà, D.; Messina, C.; Cerbone, L.; Fazzi, G.; Venturini, F.; Colasanto, R.; Necchi, A.; Bracarda, S.
Production of volatile fatty acids from cheese whey with immobilized cells
2013-01-01 Joana Margarida Bendada, Domingos; Martinez, GONZALO AGUSTIN; Scoma, Alberto; Bertin, Lorenzo; Maria A. M., Reis; Fava, Fabio
Biomethane production from grape pomaces: A technical feasibility study
2013-01-01 Rebecchi, Stefano; Bertin, Lorenzo; Veronica, Vallini; Giacomo, Bucchi; Fabrizio, Bartocci; Fava, Fabio
Production of polyhydroxyalkanoates by Cupriavidus necator from treated olive mill wastewater
2013-01-01 Martinez, GONZALO AGUSTIN; Scoma, Alberto; Rebecchi, Stefano; Bertin, Lorenzo; Gerhart, Braunegg; Fava, Fabio
Production of biohydrogen and volatile fatty acids from dephenolized olive mill wastewaters in a sequential two-step anaerobic process
2013-01-01 Monti, Matilde; Bertin, Lorenzo; Scoma, Alberto; Fava, Fabio
NOVEL ABCA1 MUTATIONS IN L PATIENTS WITH SEVERE HDL DEFICIENCY WITH OR WITHOUT CLASSIC MANIFESTATIONS OF TANGIER DISEASE
2011-01-01 Zanoni, P; Fasano, T; Deegan, Pb; Park, A; Feher, Md; Gurakan, F; Favari, E; Bernini, F; Calandra, S
External validation of the novel prognostic Meet-URO score in Metastatic Renal Cell Carcinoma on First Line Immune-combination therapy. - Proceedings from the Second International Urology Cancer Summit, 27th September, Portsmouth, UK
2024-01-01 Ghose, Aruni; Signori, Alessio; Brown, Nicholas; Haywood, Sophia; Tapia, Jose; Vijay, Anupama; Cheung, Michael; Mahajan, Ishika; Fiala, Ondrej; Abrol, Ritika; Chauhan, Vishwani; Shwe Yee Soe, Yamin; Zargham, Anum; Ashley, Sophie; Smith, Michelle; Hardy, Orla; Johnston, Emma; Sarwer, Abdullah; Kyaw Tun, Kyaw; Challapalli, Amarnath; Shrestha, Roshani; Ürün, Yüksel; Meegan, James; Rescigno, Pasquale; Parkes, Joanne; Smalley, Benjamin; Anpalakhan, Shobana; Buono, Francesco; Poprach, Alexandr; Yuen Chun Teoh, Jeremy; Murianni, Veronica; Catalano, Fabio; Bimbatti, Davide; Buti, Sebastiano; Fornarini, Giuseppe; Banna, Giuseppe; Elena Rebuzzi, Sara
External validation of the GRade, Age, Nodes and Tumor (GRANT) score for patients with surgically treated papillary renal cell carcinoma. - Proceedings from the Second International Urology Cancer Summit, 27th September, Portsmouth, UK.
2024-01-01 Maffezzoli, Michele; Signori, Alessio; Buti, Sebastiano
EP.15B.05 Predictors of 30-Day Mortality after Systemic Therapy in Hospitalized Lung Cancer Patients: A Retrospective Single-Center Observational Study
2024-01-01 Peroni, M.; Leonetti, A.; Agnetti, V.; Pratticò, F.; Manini, M.; Acunzo, A.; Rapacchi, E.; Mazzaschi, G.; Perrone, F.; Bordi, P.; Trapani, S.; Bacchini, G. P.; Buti, S.; Tiseo, M.
1981P Cabozantinib plus durvalumab in patients with advanced and chemotherapy-treated urothelial carcinoma (UC) and variant histology (VH): An open-label, phase II, single-arm proof-of-concept trial: ARCADIA study. Subgroup analysis for bone metastasis
2024-01-01 Stellato, M.; Giannatempo, P.; Polymeropoulos, A.; Guadalupi, V.; Claps, M.; Ambrosini, P.; Raggi, D.; Rametta, A.; Cavalli, C.; Gusmaroli, E.; Ortega, C.; Tucci, M.; Buti, S.; Pipitone, S.; Iacovelli, R.; Calareso, G.; Alessi, A.; Procopio, G.; Miceli, R.; Necchi, A.
1716P Primary resistance to front-line immune-based combinations in patients with advanced renal cell carcinoma (ARON-1)
2024-01-01 Catalano, M.; Roviello, G.; Buti, S.; Massari, F.; Li, H.; Park, S. H.; Grande, E.; Kucharz, J.; Fiala, O.; Poprach, A.; Buchler, T.; Seront, E.; Ansari, J.; Myint, Z. W.; Bhuva, D. M.; Bamias, A.; Ghosn, M.; Andrey, S.; Santoni, M.; Santini, D.
2014P Overall survival (OS) results in phase II trial of cabozantinib (CABO) plus durvalumab (DURVA) in patients with urothelial carcinoma (UC) or non-UC variant histologies (VH) after platinum chemotherapy (ARCADIA)
2024-01-01 Giannatempo, P.; Polymeropoulos, A.; Stellato, M.; Ambrosini, P.; Gusmaroli, E.; Cavalli, C.; Guadalupi, V.; Claps, M.; Raggi, D.; Rametta, A.; Ortega, C.; Tucci, M.; Buti, S.; Pipitone, S.; Iacovelli, R.; Calareso, G.; Alessi, A.; Procopio, G.; Miceli, R.; Necchi, A.
LBA77 Fecal microbiota transplantation (FMT) versus placebo in patients receiving pembrolizumab plus axitinib for metastatic renal cell carcinoma: Preliminary results of the randomized phase II TACITO trial
2024-01-01 Ciccarese, C.; Porcari, S.; Buti, S.; Fornarini, G.; Primi, F.; Giudice, G. C.; Damassi, A.; Giron Berrios, J. R.; Stumbo, L.; Arduini, D.; Severino, A.; Rondinella, D.; Masucci, L.; Sanguinetti, M.; Gasbarrini, A.; Cammarota, G.; Segata, N.; Tortora, G.; Ianiro, G.; Iacovelli, R.
Traduzione e sintesi di Corte europea dei diritti dell’uomo, Terza Sezione, 7 marzo 2017, V.K. c. Russia (ricorso n. 68059/13)
2017-01-01 Consorte, Francesca
Traduzione e sintesi di Corte europea dei diritti dell’uomo, Prima Sezione, 13 aprile 2017, Tagayeva e altri c. Russia (ricorso n. 26562/07 e altri)
2017-01-01 Consorte, Francesca
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Il fallimento di un ducato. Ceti dirigenti, società e volontariato militare a Reggio Emilia | 1-gen-2021 | Solieri, Fabrizio | |
| Clinical and Serological Characteristics of Sjogren's Disease-related Lymphocytic Interstitial Pneumonia: A Large Multicenter Study | 1-gen-2024 | La Rocca, G; Ferro, F; Sebastiani, M; Manfredi, A; Vacchi, C; Bocci, Eb; Nicchi, M; Atzeni, F; Crac, F; Guiducci, S; Cometi, L; Quartuccio, L; Treppo, E; Manfr, V; Mosca, M; Baldini, C | |
| Clinical parameters for first-line immuno-combinations choice in metastatic renal cell carcinoma (mRCC) patients (pts): the Meet-URO 33 study | 1-gen-2024 | Cavasin, N.; Bimabatti, D.; Signori, A.; Basso, U.; Fratino, L.; Bronte, E.; De Tursi, M.; Pierantoni, F.; Ortega, C.; Zago, G.; De Vivo, R.; Buffoni, M.; Bracarda, S.; Iacovelli, R.; Silvia, C.; Fantinel, E.; Rescigno, P.; Banna, G. L.; Buti, S.; Rebuzzi, S. E. | |
| Correlation between body composition (BC) and outcomes in mRCC patients (pts) in first line therapy (1L tp) | 1-gen-2024 | Tchawa Tchamake, J. C.; Baldessari, C.; Farioli, F.; Agresti, G.; Maruzzo, M.; Basso, U.; Buti, S.; Favaretto, A.; D’Agostino, E.; Bacchelli, F.; Oltrecolli, M.; Pirola, M.; Roccabruna, S.; Caffari, E.; Pugliese, G.; Pipitone, S.; Vitale, M. G.; Fiocchi, F.; Dominici, M.; Sabbatini, R. | |
| Overall survival (OS) results in phase II Trial of Cabozantinib (CABO) plus durvalumab (DURVA) in patients with urothelial carcinoma (UC) or non- UC variant histologies (VH) after platinum chemotherapy (ARCADIA). | 1-gen-2024 | Stellato, M.; Polymeropoulos, A.; Guadalupi, V.; Ambrosini, P.; Gusmaroli, E.; Cavalli, C.; Claps, M.; Raggi, D.; Rametta, A.; Ortega, C.; Tucci, M.; Buti, S.; Pipitone, S.; Iacovelli, R.; Calareso, G.; Alessi, A.; Procopio, G.; Miceli, R.; Necchi, A.; Giannatempo, P. | |
| P254 REAl-world Data from an Italian Compassionate Use Program (CUP) of avelumab first- Line Maintenance (1LM) for locallY advanced or metastatic Urothelial Carcinoma (la/mUC): Outcomes from the READY study in patients (pts) with low tumor burden | 1-gen-2024 | Antonuzzo, L.; Maruzzo, M.; De Giorgi, U.; Santini, D.; Tambaro, R.; Buti, S.; Carrozza, F.; Calabrò, F.; Di Lorenzo, G.; Fornarini, G.; Iacovelli, R.; Cullurà, D.; Messina, C.; Cerbone, L.; Fazzi, G.; Venturini, F.; Colasanto, R.; Necchi, A.; Bracarda, S. | |
| Production of volatile fatty acids from cheese whey with immobilized cells | 1-gen-2013 | Joana Margarida Bendada, Domingos; Martinez, GONZALO AGUSTIN; Scoma, Alberto; Bertin, Lorenzo; Maria A. M., Reis; Fava, Fabio | |
| Biomethane production from grape pomaces: A technical feasibility study | 1-gen-2013 | Rebecchi, Stefano; Bertin, Lorenzo; Veronica, Vallini; Giacomo, Bucchi; Fabrizio, Bartocci; Fava, Fabio | |
| Production of polyhydroxyalkanoates by Cupriavidus necator from treated olive mill wastewater | 1-gen-2013 | Martinez, GONZALO AGUSTIN; Scoma, Alberto; Rebecchi, Stefano; Bertin, Lorenzo; Gerhart, Braunegg; Fava, Fabio | |
| Production of biohydrogen and volatile fatty acids from dephenolized olive mill wastewaters in a sequential two-step anaerobic process | 1-gen-2013 | Monti, Matilde; Bertin, Lorenzo; Scoma, Alberto; Fava, Fabio | |
| NOVEL ABCA1 MUTATIONS IN L PATIENTS WITH SEVERE HDL DEFICIENCY WITH OR WITHOUT CLASSIC MANIFESTATIONS OF TANGIER DISEASE | 1-gen-2011 | Zanoni, P; Fasano, T; Deegan, Pb; Park, A; Feher, Md; Gurakan, F; Favari, E; Bernini, F; Calandra, S | |
| External validation of the novel prognostic Meet-URO score in Metastatic Renal Cell Carcinoma on First Line Immune-combination therapy. - Proceedings from the Second International Urology Cancer Summit, 27th September, Portsmouth, UK | 1-gen-2024 | Ghose, Aruni; Signori, Alessio; Brown, Nicholas; Haywood, Sophia; Tapia, Jose; Vijay, Anupama; Cheung, Michael; Mahajan, Ishika; Fiala, Ondrej; Abrol, Ritika; Chauhan, Vishwani; Shwe Yee Soe, Yamin; Zargham, Anum; Ashley, Sophie; Smith, Michelle; Hardy, Orla; Johnston, Emma; Sarwer, Abdullah; Kyaw Tun, Kyaw; Challapalli, Amarnath; Shrestha, Roshani; Ürün, Yüksel; Meegan, James; Rescigno, Pasquale; Parkes, Joanne; Smalley, Benjamin; Anpalakhan, Shobana; Buono, Francesco; Poprach, Alexandr; Yuen Chun Teoh, Jeremy; Murianni, Veronica; Catalano, Fabio; Bimbatti, Davide; Buti, Sebastiano; Fornarini, Giuseppe; Banna, Giuseppe; Elena Rebuzzi, Sara | |
| External validation of the GRade, Age, Nodes and Tumor (GRANT) score for patients with surgically treated papillary renal cell carcinoma. - Proceedings from the Second International Urology Cancer Summit, 27th September, Portsmouth, UK. | 1-gen-2024 | Maffezzoli, Michele; Signori, Alessio; Buti, Sebastiano | |
| EP.15B.05 Predictors of 30-Day Mortality after Systemic Therapy in Hospitalized Lung Cancer Patients: A Retrospective Single-Center Observational Study | 1-gen-2024 | Peroni, M.; Leonetti, A.; Agnetti, V.; Pratticò, F.; Manini, M.; Acunzo, A.; Rapacchi, E.; Mazzaschi, G.; Perrone, F.; Bordi, P.; Trapani, S.; Bacchini, G. P.; Buti, S.; Tiseo, M. | |
| 1981P Cabozantinib plus durvalumab in patients with advanced and chemotherapy-treated urothelial carcinoma (UC) and variant histology (VH): An open-label, phase II, single-arm proof-of-concept trial: ARCADIA study. Subgroup analysis for bone metastasis | 1-gen-2024 | Stellato, M.; Giannatempo, P.; Polymeropoulos, A.; Guadalupi, V.; Claps, M.; Ambrosini, P.; Raggi, D.; Rametta, A.; Cavalli, C.; Gusmaroli, E.; Ortega, C.; Tucci, M.; Buti, S.; Pipitone, S.; Iacovelli, R.; Calareso, G.; Alessi, A.; Procopio, G.; Miceli, R.; Necchi, A. | |
| 1716P Primary resistance to front-line immune-based combinations in patients with advanced renal cell carcinoma (ARON-1) | 1-gen-2024 | Catalano, M.; Roviello, G.; Buti, S.; Massari, F.; Li, H.; Park, S. H.; Grande, E.; Kucharz, J.; Fiala, O.; Poprach, A.; Buchler, T.; Seront, E.; Ansari, J.; Myint, Z. W.; Bhuva, D. M.; Bamias, A.; Ghosn, M.; Andrey, S.; Santoni, M.; Santini, D. | |
| 2014P Overall survival (OS) results in phase II trial of cabozantinib (CABO) plus durvalumab (DURVA) in patients with urothelial carcinoma (UC) or non-UC variant histologies (VH) after platinum chemotherapy (ARCADIA) | 1-gen-2024 | Giannatempo, P.; Polymeropoulos, A.; Stellato, M.; Ambrosini, P.; Gusmaroli, E.; Cavalli, C.; Guadalupi, V.; Claps, M.; Raggi, D.; Rametta, A.; Ortega, C.; Tucci, M.; Buti, S.; Pipitone, S.; Iacovelli, R.; Calareso, G.; Alessi, A.; Procopio, G.; Miceli, R.; Necchi, A. | |
| LBA77 Fecal microbiota transplantation (FMT) versus placebo in patients receiving pembrolizumab plus axitinib for metastatic renal cell carcinoma: Preliminary results of the randomized phase II TACITO trial | 1-gen-2024 | Ciccarese, C.; Porcari, S.; Buti, S.; Fornarini, G.; Primi, F.; Giudice, G. C.; Damassi, A.; Giron Berrios, J. R.; Stumbo, L.; Arduini, D.; Severino, A.; Rondinella, D.; Masucci, L.; Sanguinetti, M.; Gasbarrini, A.; Cammarota, G.; Segata, N.; Tortora, G.; Ianiro, G.; Iacovelli, R. | |
| Traduzione e sintesi di Corte europea dei diritti dell’uomo, Terza Sezione, 7 marzo 2017, V.K. c. Russia (ricorso n. 68059/13) | 1-gen-2017 | Consorte, Francesca | |
| Traduzione e sintesi di Corte europea dei diritti dell’uomo, Prima Sezione, 13 aprile 2017, Tagayeva e altri c. Russia (ricorso n. 26562/07 e altri) | 1-gen-2017 | Consorte, Francesca |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Articolo su rivista1731
Data di pubblicazione
- 2020 - 2024168
- 2010 - 2019825
- 2000 - 2009512
- 1990 - 1999174
- 1980 - 198951
- 1979 - 19791
Editore
- ELSEVIER19
- SAGE PUBLICATIONS LTD17
- DIKE GIURIDICA15
- Elsevier13
- ASCO pubs11
- ASCO6
- ELSEVIER IRELAND LTD5
- ELSEVIER SCIENCE INC5
- SAGE5
- TIPOGRAFIA PUBLISTAMPA S.N.C.4
Rivista
- DIGESTIVE AND LIVER DISEASE101
- GASTROENTEROLOGY100
- ANNALS OF ONCOLOGY89
- BLOOD89
- JOURNAL OF CLINICAL ONCOLOGY57
- HAEMATOLOGICA56
- NEUROLOGICAL SCIENCES46
- UNITED EUROPEAN GASTROENTEROLOGY ...46
- ANNALS OF THE RHEUMATIC DISEASES30
- REUMATISMO26
Keyword
- Helicobacter pylori10
- sclerosi sistemica6
- Bioengineering5
- Gastroenterology5
- HCV5
- UV5
- GERD4
- anodal stimulation3
- beat-to-beat variability of cardi...3
- capillaroscopia3
Lingua
- eng900
- ita177
- fre1
Accesso al fulltext
- no fulltext1699
- reserved26
- open6